Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study
Aleksey Shatunov(University of Cambridge), Ammar Al‐Chalabi(King's College London), Philip Van Damme(Universitair Ziekenhuis Leuven), Amy W. Butler(Medical Research Council), John E. Landers(University of Massachusetts Chan Medical School), John Hardy(UK Dementia Research Institute), Robert H. Brown(University of Massachusetts Chan Medical School), Vincenzo Silani(University of Milan), Orla Hardiman(Trinity College), Bryan J. Traynor(National Institutes of Health), Judith Melki(Inserm), Olubunmi Abel(King's College London), Cathryn M. Lewis(King's College - North Carolina), Peter McGuffin(King's College London), Hardev Pall(University Hospitals Birmingham NHS Foundation Trust), P. Nigel Leigh(University of Leeds), Vincent Meininger(Sorbonne Université), Bradley Smith(University of Notre Dame), Christopher E. Shaw(King's College London), Isabella Fogh(King's College London), Jan H. Veldink(University Medical Center Utrecht), Leonard H. van den Berg(University Medical Center Utrecht), Michael A. van Es(University Medical Center Utrecht), Kin Y. Mok(School of the Art Institute of Chicago), Pamela J. Shaw(University of Sheffield), Karen Morrison(University Hospitals Birmingham NHS Foundation Trust), Adriano Chiò(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Caroline Vance(King's College London), Peter M. Andersen(Umeå University), Michael E. Weale(Guy's Hospital), Lauren Johnson(King's College London), Wim Robberecht(KU Leuven), Jonathan D. Glass(Emory University), Richard W. Orrell(National Hospital for Neurology and Neurosurgery), Stephen Newhouse(University College London), Anne Farmer(King's College London), John Powell(King's College London)
Cited by 226
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k